Viatris Inc (VTRS) Financial Statements (2026 and earlier)

Company Profile

Business Address 1000 MYLAN BOULEVARD
CANONSBURG, PA 15317
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7731,0291,295739844 
Cash and cash equivalent7359921,260701844 
Short-term investments38373538  
Restricted cash and investments12356 
Receivables2,6752,8243,2443,7743,891 
Inventory, net of allowances, customer advances and progress billings3,8543,4703,5203,9785,472 
Inventory3,8543,4703,5203,9785,472 
Prepaid expense141156195257268 
Other current assets3872711,4041,4671,236 
Other undisclosed current assets1,6895,2259766831,150 
Total current assets:9,52112,97610,63510,90312,868 
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,6662,7603,0253,1893,460 
Intangible asset, including goodwill, after accumulated amortization26,20429,04833,03338,24842,030 
Goodwill9,1339,86710,42612,11412,347 
Intangible asset, excluding goodwill, after accumulated amortization17,07119,18122,60726,13429,683 
Deferred income tax assets7536939261,3332,148 
Other noncurrent assets2,3572,2092,4041,1711,048 
Total noncurrent assets:31,98034,70939,38743,94048,686 
TOTAL ASSETS:41,50147,68650,02254,84361,553 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,0462,1652,0461,8942,193 
Taxes payable237289 
Accounts payable1,8541,9381,7671,6571,904 
Accrued liabilities193227280   
Debt1     
Other liabilities3,7253,3943,4414,6204,961 
Other undisclosed current liabilities82,2191,2593,3713,409 
Total current liabilities:5,7797,7776,7469,88410,563 
Noncurrent Liabilities
Long-term debt and lease obligation14,03916,18818,01519,91822,659 
Long-term debt, excluding current maturities14,03916,18818,01519,71722,429 
Liabilities, other than long-term debt, including:3,047250245233506 
Deferred income tax liabilities1,1081,7362,4322,8153,124 
Liability for uncertainty in income taxes  399415426470 
Liability, pension and other postretirement and postemployment benefits  5045458761,020 
Restructuring reserve  596064135 
Disposal group, including discontinued operation, liabilities  77    
Other liabilities1,9391,5171,7571,9342,483 
Operating lease, liability  165181201230 
Other undisclosed liabilities, other than long-term debt  (4,208)(5,145)(5,883)(6,726) 
Other undisclosed noncurrent liabilities  3,0033,9444,3154,872 
Total noncurrent liabilities:17,08619,44122,20424,46628,036 
Total liabilities:22,86527,21828,95034,35038,599 
Equity
Equity, attributable to parent18,63620,46721,07220,49322,954 
Common stock12121212120
Treasury stock, value(504)(252)    
Additional paid in capital18,92218,81518,64618,53618,439 
Accumulated other comprehensive loss(3,213)(2,747)(2,761)(1,744)(858) 
Retained earnings (accumulated deficit)3,4194,6405,1763,6895,361 
Receivable from shareholders or affiliates for issuance of capital stock      (0)
Total equity:18,63620,46721,07220,49322,954 
TOTAL LIABILITIES AND EQUITY:41,50147,68650,02254,84361,553 

Income Statement (P&L) ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues14,73915,42716,26317,88611,946 
Cost of revenue
(Cost of Product and Service Sold)
(9,116)(8,988)(9,766)(12,311)(8,149) 
Gross profit:5,6246,4396,4975,5763,797 
Operating expenses(5,614)(5,672)(4,882)(5,610)(4,008) 
Operating income (loss):107661,615(34)(211) 
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(83)101,7916(13) 
Interest and debt expense  (573)(592)(636)(498) 
Income (loss) from continuing operations before equity method investments, income taxes:(73)2032,813(664)(721) 
Other undisclosed loss from continuing operations before income taxes(550)     
Income (loss) from continuing operations before income taxes:(623)2032,813(664)(721) 
Income tax expense (benefit)(11)(148)(735)(605)51 
Income (loss) from continuing operations:(634)552,079(1,269)(670) 
Loss before gain (loss) on sale of properties:(1,269)(670) 
Net income (loss) available to common stockholders, diluted:(634)552,079(1,269)(670) 

Comprehensive Income ($ in millions)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(634)552,079(1,269)(670) 
Other comprehensive income (loss)(466)14(1,017)(886)939 
Comprehensive income (loss), net of tax, attributable to parent:(1,100)691,062(2,155)269 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: